Technical indicators show a slight dip but fundamentals from the strong real‑world outcomes for the IN.PACT AV balloon still support upside. Minor liquidity concerns are offset by Mizuho’s positive Q1 view, so the trend remains bullish.

Market sentiment remains positive as analysts highlight durable product outcomes, though recent target cuts introduce short‑term volatility. With dividend yield above 3%, investors still find MDT attractive, maintaining a bullish outlook.

Risk profile unchanged, but recent price target reductions signal a more conservative valuation environment; downside risk marginally increased if Q1 settlement underperforms. Despite this, long‑term growth prospects from the drug‑coated balloon remain intact, keeping us bullish.

Data‑driven indicators show a minor retracement but the moving‑average crossover remains bullish, and RSI stays below resistance. The 12‑month real‑world outcomes remain favorable, reaffirming the bullish stance.